WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Xilio Therapeutics revenue was $6.34M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.7M, down 23.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XLO annual revenue was $6.3M, with Infinity% growth year-over-year.

XLO revenue history

Current Revenue
$6.3M
Current Earnings
-$58.2M
Current Profit Margin
-918%

Be the first to know when XLO announces revenue.

XLO Revenue History By Year

XLO Yearly RevenueXLO RevenueXLO ChangeXLO Revenue Growth
2024-12-31$6.34MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Xilio Therapeutics Revenue FAQ

What was XLO's revenue last quarter?

Xilio Therapeutics (NASDAQ: XLO) reported Q4 2024 revenue of $1.72 million up Infinity% year over year. In the same quarter last year, Xilio Therapeutics's revenue was $0.00.

What was Xilio Therapeutics's revenue in 2024?

Xilio Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $6.34 million, a Infinity% increase year over year.

How much does Xilio Therapeutics make in a day?

Based on Xilio Therapeutics annual revenue for the past five years, XLO makes an average of $3,476.16 per day.

What was Xilio Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Xilio Therapeutics's revenue has grown null year over year. Xilio Therapeutics's revenue in the past year totaled $6.34 million.

How much does Xilio Therapeutics make in a year?

Xilio Therapeutics's revenue by year for the past five years is:
  • Xilio Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $6.34 million, a Infinity% increase year over year.
  • Xilio Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Xilio Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Xilio Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Xilio Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.